No black box warning on record for Zafirlukast

As of the latest FDA labeling reviewed, Zafirlukast (ZAFIRLUKAST) does not carry a black box warning. Standard warnings and precautions still apply — see the full Zafirlukast medicine page for the complete safety profile.

Other warnings & precautions

WARNINGS Hepatotoxicity Cases of life-threatening hepatic failure have been reported in patients treated with zafirlukast. Cases of liver injury without other attributable cause have been reported from post-marketing adverse event surveillance of patients who have received the recommended dose of zafirlukast (40 mg/day). In most, but not all post-marketing reports, the patient’s symptoms abated an

No black box warning on record for Zafirlukast

Other warnings & precautions

WARNINGS Hepatotoxicity Cases of life-threatening hepatic failure have been reported in patients treated with zafirlukast. Cases of liver injury without other attributable cause have been reported from post-marketing adverse event surveillance of patients who have received the recommended dose of zafirlukast (40 mg/day). In most, but not all post-marketing reports, the patient’s symptoms abated an

Zafirlukast Black Box Warning

No black box warning on record for Zafirlukast

Other warnings & precautions

Zafirlukast Black Box Warning

No black box warning on record for Zafirlukast

Other warnings & precautions